Safety of pembrolizumab dosing 6-weekly versus 3-weekly
Latest Information Update: 03 Feb 2022
Price :
$35 *
At a glance
- Drugs Pembrolizumab (Primary)
- Indications Cancer
- Focus Adverse reactions
- 16 Oct 2020 New trial record
- 21 Sep 2020 Results presented at the 45th European Society for Medical Oncology Congress